GLP-1s Good for Marriage Prospects? RFK Jr.’s Diabetes Ads Axed; CGMs for Toddlers

GLP-1 drugs did not appear to improve diabetes patients’ job or marriage prospects, according to a working paper from the National Bureau of Economic Research. (Axios)

The U.S. by 2035 will have 57 million overweight individuals and 94 million people with obesity, GlobalData projected.

A nationwide study from Sweden found that diabetes patients taking GLP-1 agonists had a higher risk of the potentially blinding eye condition anterior ischemic optic neuropathy compared with those on SGLT2 inhibitors, though absolute risks were small. (Annals of Internal Medicine)

The White House canceled Health Secretary Robert F. Kennedy Jr.’s multi-million-dollar ad campaign focused on processed food and diabetes, reportedly due to costs and other concerns. (NOTUS)

A BMJ Global Health study found that early menopause affects one in 14 women ages 30 to 49 in low- and middle-income nations.

Experts raised concerns about the use of continuous glucose monitors (CGMs) in healthy children as young as 2 years. (STAT)

Nestlé is reportedly reformulating products to counter the dulled taste perception that might be experienced by patients on GLP-1 receptor agonists. (Quartz)

Clinicians should pivot to identifying imminent fracture risk rather than relying solely on traditional 10-year forecasts, researchers urged. (Journal of Clinical Endocrinology & Metabolism)

Off-label testosterone therapy in men without evidence of hypogonadism was linked to a higher risk of major cardiovascular events out to 10 years, real-world data indicated. (eBioMedicine)

The Trump administration is abandoning its plan to block Medicare and Medicaid funding for hospitals that provide gender-affirming care for youth. (NPR)

While electronic health records predominantly tracked the physical symptoms of menopause, researchers found that women overwhelmingly turned to online forums to discuss its emotional and cognitive toll. (JAMA Network Open)

Wimbledon finalist Alexander Zverev is using his platform to raise awareness about type 1 diabetes. (AP)